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INTRODUCTION
New research finds that the 2021 outbreak 
of Ebola virus disease (EVD) in Guinea orig-
inated in viral resurgence from a persistently 
infected survivor from the major 2013–2016 
epidemic 5–7 years ago1 prompting an 
urgent need to re- evaluate whether past 
EVD epidemics hitherto considered as inde-
pendent zoonotic spillovers may have had 
similar origins. Here, we reconsider local 
accounts from the West African epidemic that 
trace its origins to people, dismissed until now 
as implausible. We thus reinterpret existing 
scientific accounts of other alleged spillovers, 
finding that several past outbreaks probably 
originated in persistent infections over even 
longer latency. By recalibrating the balance 
between ‘spillover’ and ‘flare- up’, we suggest 
that EVD manifests less as a series of discrete 
epidemics and more as an endemic disease 
in humans over long timescales and wide 
areas, helping to account for the increasing 
frequency of episodes.
LOCAL ACCOUNTS
Epidemiologists identified the index case of 
the West African epidemic to be an infant in 
the small village of Meliandou in Guinea’s 
Forest Region,2 and a multidisciplinary team 
suggested he was infected from a Mops condy-
lurus bat colony.3
During DM’s scoping visits in 2016, 
however, some villagers, including Melian-
dou’s community health- worker, explained 
that a woman named ‘Fanta’ seeking treat-
ment from a noted village healer brought 
EVD to the village. She had come from the 
diamond region of Sefadou in nearby Sierra 
Leone immediately before the outbreak in 
December 2013, but had first visited several 
months earlier after being referred to the 
healer by doctors at Gueckedou hospital. The 
healer said that Fanta suffered from Gnan-
gafoo in his Kissi language, for which he was 
a specialist. Understood usually as a socially 
caused affliction, this manifests in itchy skin 
over much of the body and hair loss; Fanta 
had these symptoms.
Fanta initially lodged with the healer for 
about 2 months but also befriended the 
mother and grandmother of the infant ‘index 
case’. The healer recalled how Fanta and this 
infant’s mother ‘ate, slept and did everything 
together’ with Fanta often carrying the infant 
on her back. After recovering somewhat, 
Fanta left for Sierra Leone but returned to 
finish treatment just prior to the outbreak. As 
the healer was travelling, his wife said that she 
only stayed 5 days or less and had ‘no symp-
toms of disease’. The residential community 
health- worker explained how:
Summary box
 ► That the 2021 outbreak of Ebola virus disease (EVD) 
in Guinea originated in viral resurgence from a survi-
vor infected 5–7 years ago requires local and scien-
tific accounts of past outbreaks to be revisited.
 ► Many past EVD epidemics hitherto considered as in-
dependent zoonotic spillovers may have originated 
from similar flare- ups even after decades, prompting 
reconsideration of EVD more as an endemic disease 
over long timescales and wide areas than as a series 
of discrete epidemics, and accounting for increasing 
outbreak frequency.
 ► Key assumptions in analysis of phylogenetics and 
of the ecology and drivers of Ebola virus (EBOV) 
spillover from wildlife hosts such as bats need to be 
reassessed.
 ► More collaborative, respectful approaches with local 
communities are needed to understand the origins 
of outbreaks, to address them and to support rather 
than stigmatise sufferers and survivors.
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In my humble opinion, it is a certain Fanta … who brought 
us this illness. She suffered from a severe skin complaint 
that she came to treat here. She was healed. She left back 
to Sierra Leone and then returned for a second time. 
She slept in the same bed, cooked and ate with [the in-
dex case’s grandmother]… Several days after she left, [the 
grandmother] fell ill with joint pains and headaches. She 
recovered initially. A few days later deaths struck the family. 
Six died rapidly in the family that welcomed Fanta.
Variants of this narrative circulate in the region 
(Gbanace et al, 2014)4 describing Fanta’s friendship with 
a former Sierra Leonean soldier who had returned from 
the Democratic Republic of Congo (DRC). Villagers told 
DM, too, that Fanta was linked to a diamond dealing or 
mining family across the border. The virus phylogenetics 
suggest that the West African outbreak has a common 
origin with the virus circulating in diamondiferous 
regions of the Luebo outbreak in DRC in 2007/2008, 
diverging from it in c.2004.5
Researchers who traced EVD to Meliandou heard 
narratives concerning Fanta but rejected them as she had 
no Ebola symptoms as then known, and had arrived with 
Gnangafoo months before the outbreak, far longer than 
the EVD incubation and infection period. It was then 
believed that Ebola patients either died or recovered, 
clearing active virus from their body. This reasoning 
cannot now be upheld. First, the symptoms that brought 
Fanta to Meliandou are now known to be common 
sequelae of post- Ebola syndrome.6 Second, flare- ups of 
EVD have been traced to ‘survivors’ in at least 13 instances 
during or within 2 years of the West African epidemic, 
with the new evidence now extending this to 7.7 8 Third, 
oral accounts link Fanta with DRC and despite their ambi-
guities, they render infection from DRC plausible when 
combined with evidence of longer- term persistence.
Modes of Ebola virus (EBOV) persistence and latency 
are inadequately known but are associated with immune- 
privileged organs. Published research on persistence in 
women and children is lacking but EBOV genomic mate-
rial in semen can correlate with eye and joint pain9 and 
has also been detected in asymptomatic survivors and 
even following multiple prior negative samples.10 Resur-
gence may be associated with immunocompromised 
states, including pregnancy, poverty and poor nutrition, 
and co- infections such as with HIV.11 The epidemiolog-
ical team speculated that Fanta may have been suffering 
AIDS but had no reason to contemplate co- infection with 
EBOV. Transmission from resurgence can occur from 
men’s sperm and from mother to baby through breast-
feeding.12 The potential for congenital infection has not 
been considered.
WERE EARLIER SPILLOVERS ACTUALLY FLARE-UPS?
Given the new Guinea evidence of flare- up over much 
longer timescales, it is important to reassess whether 
some past outbreaks once deemed spillovers are better 
explained as flare- ups. Ebola has often returned to the 
same locations after 1 year or 2 years. The Sudan Ebola 
virus variant struck the same cotton factory in South 
Sudan twice in 1976 and 1979 and the received view of 
two separate spillovers now seems unlikely,13 although 
the phylogenetic evidence needed to confirm this is not 
available. In the two outbreaks in Luebo in DRC in 2007 
and 2008, the virus was almost identical and must have 
remained persistent or latent in some way. To explain this 
as spillover, Leroy and colleagues speculated that the very 
same migratory fruit bat that they claimed had brought 
the virus in 2007 must have infected a bat of another non- 
migratory species which then infected the ‘patient zero’ 
a year later.14 15 Given what we now know, however, this 
second case would unquestionably be investigated as a 
flare- up.
While these paired outbreaks were in the same place 
and within short timescales, an aptly titled paper on 
the ‘Puzzling origins of the Ebola outbreak in the Democratic 
Republic of the Congo, 2014’16 also suggested the signifi-
cance of longer- term persistence linking outbreaks across 
regions. The 2014 outbreak was phylogenetically close to 
outbreaks in equatorial Africa in 1994, a similarity far 
greater than expected given mutation rates linked to viral 
replication. Baffled, the researchers speculated that the 
virus was maintained as latent or persistent in an animal 
host but did not contemplate long- term viral persistence 
in people.
Among the recent outbreaks, one in 2018 in Équa-
teur (DRC) was related to this same 2014 outbreak, yet 
explanations have still been sought only in latency within 
animal reservoirs and subsequent spillover.17 Another 
outbreak in Équateur in 2020 was composed of two 
distinct viral variants, one of which was so similar to the 
2018 outbreak that persistence in people had to be consid-
ered, but again researchers still preferred to hypothesise 
persistence in an animal reservoir.18 The outbreak in 
North Kivu in 2021 is accepted as a flare- up from the 
outbreak there in 2018–2020; this, in turn, was so close to 
an outbreak in Likati (DRC) in 2017 that latency has had 
to be invoked, but again is being projected to have been 
in an animal reservoir.19
CONCLUSIONS
There are wide- ranging implications for science and 
policy. That many outbreaks may originate in flare- ups 
does not negate the possible origins of EVD epidemics in 
spillover from animal reservoirs, but does demand ques-
tioning of the balance between these explanations. While 
some outbreaks may be new spillovers, and the circula-
tion of multiple EBOV variants in diverse animal reser-
voirs with potential to spillover as claimed by researchers 
in 200420 suggests this, it is increasingly clear that other 
outbreaks are from latency. And whereas most research 
effort to date infers latency in animal reservoirs, the new 
evidence from Guinea demands a refocusing on the 
significance and mechanisms of latency in people.
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Tilting the balance towards flare- ups, including those 
at the decadal timescale, suggests that EVD should be 
reconceived less as a series of discrete epidemics, but 
more as an already endemic disease (although usually in 
latent form) from which outbreaks occur linked to resur-
gence, some of which become epidemics.
Further research will need to take local accounts and 
their social underpinnings far more seriously, triangu-
lating with advances in phylogenetic and ecological anal-
ysis. There are new challenges for phylogenetic analysis to 
explore the implications of latency in people, including 
the possibility of resurgence after many decades or even 
across generations. Ecological analysis mapping environ-
mental and demographic drivers of spillover by associ-
ating outbreaks with deforestation and encroachment 
on wildlife must be revisited. That spillover from bats has 
been incorrectly pinpointed in at least some instances 
requires attention to how representations of EVD’s 
origins in nature are being over- determined by existing 
expert discursive formations, and under- determined 
by local knowledge. Narrative closure among scientists 
around locally untenable explanations only fuels distrust.
The implications for global health are enormous. 
EVD outbreaks are rapidly increasing in frequency; a 
frequency which we can now speculate self- multiplies with 
the growing number of survivors and thus possible gener-
ation of flare- ups, exacerbated by conditions for resur-
gence that might include co- infections and poverty. All 
this has gone ‘under the radar’ amid predominant atten-
tion to zoonotic spillover. These new findings will worry 
and may further stigmatise EVD sufferers, so reaffirm the 
need to support them, their families and communities 
over much longer timescales, and through destigma-
tising approaches that treat them as people with dignity 
affected by a disease, rather than seeing them through 
the lens of the disease and as a global public health risk. 
Experience needs to be drawn from other illnesses where 
those infected remain a long- term source of human infec-
tion, and have then been subjected to counterproductive 
and repressive social and public health reactions.
Finally, it is all the more imperative to reduce the 
number of sufferers and future survivors and spot and 
curtail EVD outbreaks at an early stage. More attention 
needs to be paid to collaborative, respectful approaches 
with local communities both to understand the origins of 
outbreaks and to address them.
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